Burning Rock Biotech (BNR) Common Equity (2020 - 2025)
Historic Common Equity for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $77.2 million.
- Burning Rock Biotech's Common Equity fell 1641.78% to $77.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.2 million, marking a year-over-year decrease of 1641.78%. This contributed to the annual value of $79.6 million for FY2024, which is 2647.63% down from last year.
- Burning Rock Biotech's Common Equity amounted to $77.2 million in Q3 2025, which was down 1641.78% from $78.8 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Common Equity peaked at $356.2 million during Q1 2021, and registered a low of $77.2 million during Q3 2025.
- In the last 5 years, Burning Rock Biotech's Common Equity had a median value of $133.4 million in 2023 and averaged $170.5 million.
- As far as peak fluctuations go, Burning Rock Biotech's Common Equity crashed by 4291.74% in 2022, and later plummeted by 1555.83% in 2025.
- Burning Rock Biotech's Common Equity (Quarter) stood at $289.6 million in 2021, then plummeted by 42.0% to $167.9 million in 2022, then crashed by 35.56% to $108.2 million in 2023, then decreased by 26.48% to $79.6 million in 2024, then dropped by 2.98% to $77.2 million in 2025.
- Its Common Equity was $77.2 million in Q3 2025, compared to $78.8 million in Q2 2025 and $78.8 million in Q1 2025.